Radiosensitizers in cervical cancer. Cisplatin and beyond

  title={Radiosensitizers in cervical cancer. Cisplatin and beyond},
  author={Myrna Candelaria and Alicia Garc{\'i}a-Arias and Lucely del Carmen Cetina and Alfonso Due{\~n}as-Gonz{\'a}lez},
  journal={Radiation Oncology (London, England)},
  pages={15 - 15}
Cervical cancer continues to be a significant health burden worldwide. Globally, the majority of cancers are locally advanced at diagnosis; hence, radiation remains the most frequently used therapeutical modality. Currently, the value of adding cisplatin or cisplatin-based chemotherapy to radiation for treatment of locally advanced cervical cancer is strongly supported by randomized studies and meta-analyses. Nevertheless, despite these significant achievements, therapeutic results are far from… CONTINUE READING